Champion Industries, Inc. CHMP
Set alert
0.02 USD 0.00 0.00%
At close · Oct 29
0.0001 Day range 0.0001
0.0001 52-week range 0.02
- YTD
- 0.00%
- 1 year
- +19,900.00%
- Open
- 0.0001
- Prev close
- 0.02
- Mkt cap
- 1.13K
- Vol
- 51
- Avg vol
- 0
- EPS
- -0.03
- P/E
- 0.00
More statistics
- Low
- 0.0001
- High
- 0.0001
Financials — quick view
CHMP Revenue — quarterly 15.87M
CHMP Net income — quarterly -81.25K
CHMP EPS — quarterly -0.01
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jun 14, 2016 | Apr 1, 2016 | 0.00 | -2.00 | — | — |
| Mar 16, 2016 | Jan 1, 2016 | 0.00 | -4.00 | — | — |
News
- Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
- Scholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights
- AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
- Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis
- Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
Your note
Sign in to keep a note on CHMP — it syncs with the Stock Master app.